Myelodysplastic hematopoiesis mimicking the bone marrow in a mediastinal myelolipoma

por Takano, Hina, Takahashi, Ken, Taki, Kazuhiro
Publicado 2017

In Vitro Self-Renewal Division of Hematopoietic Stem Cells

por Ema, Hideo, Takano, Hina, Sudo, Kazuhiro, Nakauchi, Hiromitsu
Publicado 2000

Asymmetric Division and Lineage Commitment at the Level of Hematopoietic Stem Cells: Inference from Differentiation in Daughter Cell and Granddaughter Cell Pairs

por Takano, Hina, Ema, Hideo, Sudo, Kazuhiro, Nakauchi, Hiromitsu
Publicado 2004

Acute promyelocytic leukemia presenting as recurrent spinal myeloid sarcomas 3 years before developing leukemia: A case report with review of literature

por Yamashita, Tomoko, Nishijima, Akihiko, Noguchi, Yuma, Narukawa, Kensuke, Oshikawa, Gaku, Takano, Hina
Publicado 2019

Development of Acute Adult T-cell Leukemia Following PD-1 Blockade Therapy for Lung Cancer

por Misawa, Kyohei, Yasuda, Hajime, Matsuda, Hironari, Hara, Munechika, Ochiai, Tomonori, Koyama, Daisuke, Takano, Hina, Iwao, Noriaki, Koike, Michiaki
Publicado 2022

Adult paroxysmal cold hemoglobinuria following mRNA COVID‐19 vaccination

por Misawa, Kyohei, Yasuda, Hajime, Koyama, Daisuke, Inano, Tadaaki, Inoguchi, Akemi, Shirasu, Chinami, Takano, Hina, Iwao, Noriaki, Ando, Miki, Koike, Michiaki
Publicado 2022

The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group

por Iriyama, Noriyoshi, Ohashi, Kazuteru, Hashino, Satoshi, Kimura, Shinya, Nakaseko, Chiaki, Takano, Hina, Hino, Masayuki, Uchiyama, Michihiro, Morita, Satoshi, Sakamoto, Junichi, Sakamaki, Hisashi, Inokuchi, Koiti
Publicado 2017

Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transc...

por Shiseki, Masayuki, Yoshida, Chikashi, Takezako, Naoki, Ohwada, Akira, Kumagai, Takashi, Nishiwaki, Kaichi, Horikoshi, Akira, Fukuda, Tetsuya, Takano, Hina, Kouzai, Yasuji, Tanaka, Junji, Morita, Satoshi, Sakamoto, Junichi, Sakamaki, Hisashi, Inokuchi, Koiti
Publicado 2017

Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation

por Kumagai, Takashi, Nakaseko, Chiaki, Nishiwaki, Kaichi, Yoshida, Chikashi, Ohashi, Kazuteru, Takezako, Naoki, Takano, Hina, Kouzai, Yasuji, Murase, Tadashi, Matsue, Kosei, Morita, Satoshi, Sakamoto, Junichi, Wakita, Hisashi, Sakamaki, Hisashi, Inokuchi, Koiti
Publicado 2017

Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission

por Kumagai, Takashi, Nakaseko, Chiaki, Nishiwaki, Kaichi, Yoshida, Chikashi, Ohashi, Kazuteru, Takezako, Naoki, Takano, Hina, Kouzai, Yasuji, Murase, Tadashi, Matsue, Kosei, Morita, Satoshi, Sakamoto, Junichi, Wakita, Hisashi, Sakamaki, Hisashi, Inokuchi, Koiti
Publicado 2020